A new DNA vaccine expressing HspX-PPE44-EsxV fusion antigens of Mycobacterium tuberculosis induced strong immune responses

OBJECTIVE(S): Infection with tuberculosis (TB) is regarded as a major health issue. Due to the emergence of antibiotic resistance during TB treatment, prevention via vaccination is one of the most effective ways of controlling the infection. DNA vaccines are developed at a greater pace due to their...

Descripción completa

Detalles Bibliográficos
Autores principales: Moradi, Bagher, Sankian, Mojtaba, Amini, Yousef, Gholoobi, Aida, Meshkat, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395183/
https://www.ncbi.nlm.nih.gov/pubmed/32774813
http://dx.doi.org/10.22038/ijbms.2020.38521.9171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395183/
https://www.ncbi.nlm.nih.gov/pubmed/32774813
http://dx.doi.org/10.22038/ijbms.2020.38521.9171

Ejemplares similares